Inter Parfums, Inc. (IPAR) Stock Price & How to Invest

Interparfums creates, manufactures and distributes prestige fragrances under licence from brand owners. It signs a multi-year agreement with a fashion or jewellery house, pays that house a royalty of roughly 6% to 11% of net sales, and takes on everything else: the juice, the bottle, the positioning, the advertising and the distribution into more than 120 countries. The business runs in two segments. European based operations sit inside Interparfums SA, a separately listed Paris subsidiary that Interparfums owns 72% of, and carry Jimmy Choo, Coach, Montblanc, Lacoste, Boucheron, Kate Spade, Karl Lagerfeld, Moncler and Van Cleef & Arpels; that side was about 68% of 2025 net sales. United States based operations carry GUESS, Donna Karan/DKNY, Ferragamo, Abercrombie & Fitch, Hollister, MCM, Roberto Cavalli, Graff, Oscar de la Renta and Anna Sui. A handful of brands are owned outright rather than licensed, including Rochas, Lanvin, Off-White, Goutal and the in-house Solférino line.

The investment picture turns on concentration and contract dates. Seven brands produced about 77% of 2025 sales, with Jimmy Choo at 17%, Coach and Montblanc at 15% each and GUESS at 12%, so a single non-renewal would leave a visible hole. Management has spent two years pushing those dates out: GUESS now runs to the end of 2048, Lacoste to 2038, Van Cleef & Arpels to 2033, Donna Karan/DKNY to 2032, Coach to mid-2031, Jimmy Choo and Ferragamo to the end of 2031, and Montblanc to the end of 2030. Trading has flattened in the meantime. First half 2026 sales rose 2% to $686 million while operating margin fell from 20.0% to 17.9% on heavier advertising and royalty costs, and the company reaffirmed a full year outlook of about $1.48 billion in sales and $4.85 in diluted EPS, below the $5.25 it earned in 2025. Management frames 2026 as a consolidation year ahead of a launch pipeline it has pointed at 2027 and 2028.

The structural risk is that Interparfums does not own most of what it sells, and a licensor can decline to renew or take fragrance in-house, as Alfred Dunhill did when that agreement lapsed on September 30, 2023 without renewal. Three smaller licences reach their stated end on December 31, 2026 (Anna Sui, Graff and Moncler), each with an optional extension that depends on conditions or sales targets being met, while Boucheron's main lines run to the end of 2027 and Abercrombie & Fitch and Hollister expire on March 14, 2028. Concentration compounds the point, because roughly 77% of sales sit in seven brands and Macy's alone was about 10% of 2025 net sales. Currency is a live swing factor given that about half of European segment sales are billed in dollars while nearly all of that segment's costs are in euro. There is also an option on the Lanvin trademarks that lets the seller repurchase them on July 1, 2027 for 70 million euro, roughly $82 million, which would remove an owned brand from the portfolio, and the 2026 guidance itself implies lower earnings than 2025 as advertising spend climbs back toward the company's 21% of sales target.

5 analysts publish price targets on IPAR, averaging $135.00 against a $114.63 price as of August 2026, or +17.8%. The published targets run from $120.00 to $151.00, a narrow spread, and the ratings split 2 buy, 3 hold, 0 sell. Over the last six months there have been 5 raises and 0 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full IPAR forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Inter Parfums, Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. The licence book runs long where the revenue is. Every brand that contributed 4% or more of 2025 sales now has a contractual runway of at least four years, and several stretch beyond twenty. The most optimistic published target, $151.00, assumes this works close to its best case.

The case against. The structural risk is that Interparfums does not own most of what it sells, and a licensor can decline to renew or take fragrance in-house, as Alfred Dunhill did when that agreement lapsed on September 30, 2023 without renewal. The most pessimistic target, $120.00, is roughly what IPAR is worth if this bites instead.

Read the full bull and bear case on IPAR, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Inter Parfums, Inc.'s investor relations page or your broker.

• Revenue (TTM): ~$1.50B, up ~3% year over year
• Diluted EPS (TTM): ~$5.23, against 2026 guidance of ~$4.85
• Operating margin (H1 2026): ~17.9%, down from ~20.0% a year earlier
• Net cash: ~$65M (~$211M cash and short-term investments against ~$146M of debt)
• Valuation: ~$3.67B market cap, ~22x trailing earnings and ~24x the 2026 guide
• Dividend: ~$0.80 per quarter, ~$3.20 annualised, a yield near ~2.8%

The multiple sits close to the broad market even though the earnings line is guided down this year, which tells you the market is pricing the 2027 and 2028 launch slate rather than the current run rate. Three brokers cut the stock to a hold rating in August 2026 on exactly that reasoning, arguing the pipeline was already in the price. Royalty expense of ~$121.7 million in 2025, about 8.2% of sales, is the recurring cost of the licensing model and rises with brand mix rather than with volume alone.

Other names that sit close to IPAR: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get IPAR exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so IPAR sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where IPAR fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Interparfums is a well-run royalty payer whose top seven brands are locked in past 2030, which is the reassurance and the ceiling at the same time.

Whether IPAR is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is IPAR a buy or a sell?, and where the stock could go from here in the IPAR stock forecast.

For income investors, whether IPAR pays a dividend and how the payout looks is covered in does IPAR pay a dividend? And to weigh IPAR against a peer, read the full side-by-side comparisons: IPAR vs COTY and IPAR vs LVMUY.